NovImmune

About:

NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.

Website: https://www.lightchainbio.com

Top Investors: Novartis Venture Fund, Pictet Private Equity Investors S.A., Rosetta Capital, Reference Capital SA, Aravis Ventures

Description:

NovImmmune is committed to innovation by discovering and developing therapeutic monoclonal antibodies (mAbs) to treat patients suffering from immune-related disorders.